Thyrocare Q3 FY26 Revenue Up 18%, EBITDA Surges 38% YoY

Thyrocare Technologies has announced strong financial results for Q3 FY26, with revenue increasing by 18% YoY and EBITDA surging by 38% YoY. Key highlights include growth in consolidated revenue, pathology revenue, and franchisee revenue. The company reported significant improvements in quality parameters and is expanding its lab network and franchisee reach. Madhuri Dixit has been named as the new brand ambassador.

Financial Highlights

Thyrocare Technologies reported significant growth in revenue and profitability for the third quarter of fiscal year 2026:

  • Consolidated Revenue: ₹196 Cr (up 18% YoY)
  • Standalone Revenue Growth: ₹183 Cr (up 20% YoY)
  • Franchisee Revenue Growth: ₹112 Cr (up 12% YoY)
  • Partnership Revenue Growth: ₹60 Cr (up 39% YoY)
  • EBITDA: Up 38% YoY
  • PAT: Up 47% YoY

Operational Performance

The company showcased strong operational metrics, reflecting efficient service delivery and expanding reach:

  • Samples Processed in NABL Labs: 97%
  • Tests Conducted: 49.6 Mn (up 22% YoY)
  • Complaints Per Million Tests: 3.2 (43% lower YoY)
  • Quarterly Active Franchisees: Approximately 10,300 (up 12% YoY)
  • Patients: 4.5 Mn (up 14% YoY)

Key Initiatives and Expansion

Thyrocare is focused on expanding its reach and enhancing service quality through several strategic initiatives:

  • Strengthening the Pan-India lab footprint with new labs in Davangere (Karnataka) and Mandi (Himachal Pradesh).
  • National Diagnostics Champion of the Year Award for Diagnostic excellence.
  • Nationwide network serving masses.
  • Doctor Board Advisory Meetings for insight from medical experts.
  • PAN India Franchisee meets to strengthen partnerships.

Financial Performance Details

The financial performance for Q3 FY26 and Year-to-Date (YTD) FY26 is as follows:

  • TTL Consolidated Revenue: Up 18% (Q3) and 21% (YTD)
  • Pathology Revenue: Up 20% (Q3) and 23% (YTD)
  • Radiology Revenue: Down 7% (Q3) and Up 1% (YTD)
  • Reported EBITDA: Up 38% (Q3) and 41% (YTD)

Strategic Direction

Thyrocare’s key pillars for future growth include:

  • Expanding deeper into India with focused test menu.
  • Strengthening franchise network with focus on large service providers.
  • Expanding partnerships towards insurance and ECG at home.
  • Strengthening presence in Tanzania.

Brand Ambassador

Thyrocare onboards Madhuri Dixit as the new brand ambassador.

Source: BSE

Previous Article

KRN Heat Exchanger Board Meeting Scheduled to Approve Unaudited Financial Results

Next Article

Thyrocare Board Approves Amendment to Code of Conduct for Insider Trading